Case Report: Rapid Desensitization to Ocrelizumab for Multiple Sclerosis Is Effective and Safe

Monoclonal antibodies have become a mainstay of treatment for many inflammatory diseases and malignancies. Multiple sclerosis is a chronic inflammatory, demyelinating, and neurodegenerative disease of the central nervous system and a common cause of disability in young adults. Ocrelizumab is a recom...

Descripción completa

Detalles Bibliográficos
Autores principales: Aun, Marcelo Vivolo, Freua, Fernando, Marussi, Victor Hugo Rocha, Giavina-Bianchi, Pedro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865367/
https://www.ncbi.nlm.nih.gov/pubmed/35222433
http://dx.doi.org/10.3389/fimmu.2022.840238

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865367/
https://www.ncbi.nlm.nih.gov/pubmed/35222433
http://dx.doi.org/10.3389/fimmu.2022.840238

Ejemplares similares